Эдарби® 80 мг таблетки

Country: Kyrgyzstan

Language: Russian

Source: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Active ingredient:

Азилсартан медоксомил

Available from:

Такеда Фарма А/С (Такеда Фарма А/С)

INN (International Name):

Azilsartan medoxomil

Dosage:

80 мг

Pharmaceutical form:

таблетки

Units in package:

№28

Prescription type:

по рецепту

Manufactured by:

Такеда Фармасьютикал Компани Лтд (Япония)

Product summary:

ПЖВЛС: нет

Authorization date:

2016-06-01

Summary of Product characteristics

                                yTBEPIKAATO
IIHCTPYKII}Ifl
TIO
MEA}IIIIIHCKOMY
IIPIIMEHEHIIIO
JIEKAP
CTBEHHOIO
TIPEIIAPATA
9AAPE}I@
Topronoe
Ha3BaHrIe:
3aap6u@
Mex4yu
apoAHoe
Hen
areHToBaHHoe
Ha3BaHHe
(MHH)
: a3lincapraHa
MeAoKcoMun
JlenapcrneHHaq
Soptra:
ra6lerxu.
Cocran:
I ma1nemrco
40 uz codepcrcum:
Arcmueuoe
6er4ecmso:
a3lrncapraHa
MeAoKcoMkrIt
:r.lurfis.42,68
Mr coorBercrByer
a3krlrcapraua
MeAoKcoMI4iry
40 rur
BcnouozamerbHbte
6et4ecm6a:
MaHHr.rroJI
95,63
rr.r,
tfyrr,rapoBaff
KI4cJIota2
Mr,
Harpl{ff
ru4porcla4
0,69
Mr,
fulpoJrosa
5,4
Mr,
KpocKapMeJrJro3a
Hupufl,
13,8 rrlr,
IIeJInIono3a
MI{KpoKpI{crtuurI,FIecKax
18 ur,
MarHr.rr
creapar
1,8 ur.
I
ma6nemrca
80
uz codepcrcum:
Arcmueuoe
6eu4ecm6o.'
asuncapraHa
MeAoKcoMuIrKaJrr4fl
85,36
Mr coorBercrByer
a3urcaprana
MeAoKcoMlIny
80
rrlr
BcnouozamerrbHbte
6et4ecmsa.'
MaHHT4ToJI
I9I,26lr,
(pyrr,rapoBat
KlIcJIola
4
Mr,
Hurpufl'
ru4por
na
4pyroft.
Ta6nemrcu
80 az:
Or
6enoro
Ao
rtotrrr4 6eloro
rlBera
Kpyrnble
ABoffKoBbIrIyKnbIe
ra6lerru
c
rpaBl4posKoft
(ASL)
Ha
oAnoft
cropoHe
u
<80>
Ha
4pyrofi.
@apvrarco.rrorfiqecKrre
csoft
crna
cDapnaxoduHtrruKa
AsulcapraHa
MeAoKcoMr4Jr
-
4eftcreyrouee
BetqecrBo
rlpenapara
34ap6"@
-
""Jr""rcx
cneqz(puqecKl'IM
aHTaroHr,rcroM
perle[TopoB aHfproreH3r4Ha
II
'rr4fia
I
(ATl).
Asralcaprana
MeAoKcoMI'IJI
9To
nponeKapcrBo
Anlt
[prdeMa
BHyrpb.
AsulcapraHa
MeAoKcoMI4JI
6rtcrpo
rpeBpauaerct
B
aKTI'IBHyro
Monexyny
asrrJroapraHa,
KoropaJr
ras6uparerbHo
nperltrcrByer
pa3BLITLIro
e(llpextoe
aurnoreusrHa
II
lyreM
6lorraponau?rt
ero cBfl3brBaHr{{
c
peqeflTopaMld
ATr
s
pa3nI{rIHbIX
TKaHgx.
Anraotensun
II
f,Brsercr
ilepBr.rr{HblM
Ba3oaKTr.rBHbIM
ropMoHoM
peHl,IH-ar{rkIoTeH3}IH-ilJlrAecreponosofi
crlcreMbl
(PAAC
                                
                                Read the complete document
                                
                            

Documents in other languages